Prognostic value of minimal residual disease measured by fusion‐gene transcript in infants with KMT2A ‐rearranged acute lymphoblastic leukaemia treated according to the MLL‐Baby protocol-Reference-Cited by-同舟云学术

Prognostic value of minimal residual disease measured by fusion‐gene transcript in infants with KMT2A ‐rearranged acute lymphoblastic leukaemia treated according to the MLL‐Baby protocol

Published:2021-02-14 Issue:6 Volume:193 Page:1151-1156
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Tsaur Grigory¹²³^ORCID,Popov Alexander⁴^ORCID,Riger Tatiana¹²,Kustanovich Anatoly⁵,Solodovnikov Alexander²³,Shorikov Egor⁶,Demina Anna¹²,Verzhbitskaya Tatiana¹²,Streneva Olga¹²,Makarova Olga¹,Lapotentova Elena⁷,Aleinikova Olga⁷,Miakova Natalia⁴,Boichenko Elmira⁸,Kondratchik Konstantin⁹,Ponomareva Natalia¹⁰,Karachunskiy Alexander⁴,Roumiantsev Alexander⁴,Fechina Larisa¹²

Affiliation:

1. Regional Children’s Hospital Ekaterinburg Russian Federation

2. Research Institute of Medical Cell Technologies Ekaterinburg Russian Federation

3. Ural State Medical University Ekaterinburg Russian Federation

4. National Research and Clinical Center for Pediatric Hematology Oncology and Immunology Moscow Russian Federation

5. The Sharett Institute of Oncology Hadassah Medical Center Jerusalem Israel

6. PET‐Technology Center of Nuclear Medicine Ekaterinburg Russian Federation

7. Belarussian Research Center for Pediatric Oncology, Hematology and Immunology Minsk Belarus

8. City Children’s Hospital, 1 Saint‐Petersburg Russian Federation

9. Morozov Children’s Hospital Moscow Russian Federation

10. Republican Children’s Hospital Moscow Russian Federation

Publisher